Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymoglobulin in Multiple Myeloma Candidates for Stem Cell Transplant
NCT00378768Phase 2Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Nov 2005
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of antithymocyte globulin in multiple myeloma (MM), sponsored by Fred Hutchinson Cancer Center. Started Nov 2005; status: completed.
02
Drugs
antithymocyte globulin
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00378768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00378768.